When women are informed about this, the FDA has proposed language that will help them weigh out their options. It will tell women if they should do more imaging tests or talk to their doctors.

Gottlieb noted, “Breast cancer is one of the most worrisome health concerns facing women. As part of our overall commitment to protecting the health of women, we’re proposing new policies to modernize our oversight of mammography services.”